Carlo M. Croce, MD, director of Human Cancer Genetics and the John W. Wolfe Chair in Human Cancer Genetics, has received a $1.9 million, five-year NCI grant to study microRNAs and ultra-conserved noncoding RNAs as biomarkers for cancer risk, early tumor detection, tumor progression and response to treatment.
Charles Shapiro, MD, director of Breast Medical Oncology, and KAY HUEBNER, PhD, professor of Molecular Virology, Immunology and Medical Genetics, have received a $2.5 million, five-year NCI grant to study microRNA profiles of triple-negative breast cancer to define subgroups and therapeutic targets.
Wolfgang Sadee, PhD, chair and professor of Pharmacology, of Pharmacy, of Internal Medicine, of Psychiatry and of Public Health, has received a $9.1 million, five-year grant from the National Institute of General Medical Sciences for a study titled “Expression Genetics in Drug Therapy.” The grant also funds Ohio State as a member of a nationwide Pharmacogenomics Research Network.
Awards and Honors
Michael A. Caligiuri, MD, director of the OSUCCC and CEO of the James Cancer Hospital and Solove Research Institute, is one of four scientists nationwide this year to receive a prestigious MERIT Award from the National Cancer Institute for superior competence and outstanding productivity. The award provides up to 10 years of research support.
Ching-Shih Chen, PhD, Lucius A. Wing Chair of Cancer Research & Therapy, Professor of Medicinal Chemistry, of Internal Medicine, and of Urology, has received the 2010 Innovator of the Year award from The Ohio State University for his translational research and the success of his drug discovery program.
Carlo M. Croce, MD, director of Human Cancer Genetics and the John W. Wolfe Chair in Human Cancer Genetics, has been inducted into the American Academy of Arts & Sciences, an honorary society established in 1780 by John Adams and other founders of the nation to study complex emerging problems.
Faculty and Programs
John C. Byrd, MD, holder of the D. Warren Brown Family Designated Professorship in Leukemia Research at the OSUCCC – James, has been named director of the new Division of Hematology in the Department of Internal Medicine.
Philip Payne, PhD, a member of the Experimental Therapeutics Program, has been named chair of the Department of Biomedical Informatics at Ohio State.
Richard D. White, MD, FACR, has been appointed chair of the Department of Radiology and director of the Imaging Signature Program.
Michael A. Caligiuri, MD, director of the OSUCCC and CEO of the James Cancer Hospital and Solove Research Institute, has been elected to serve as councilor on the American Society of Hematology’s (ASH) Executive Committee in 2011. He will attend Executive Committee meetings and serve on a Clinical Research Training Institute Oversight Subcommittee, among other duties.
William E. Carson III, MD, associate director for Clinical Research, and JEFF A. WALKER, MBA, executive director of the OSUCCC – James, have joined the board of directors for the National Comprehensive Cancer Network, an alliance of 21 leading cancer centers dedicated to improving the quality and effectiveness of cancer care.
Michael Lairmore, DVM, PhD, associate dean for research and graduate studies and professor in the College of Veterinary Medicine at The Ohio State University, was named a member of the national Institute of Medicine, the health arm of the National Academy of Sciences.
Thomas Rosol, DVM, PhD, professor of Veterinary Biosciences and special assistant to the vice president for Research, has been elected by the American Veterinary Medical Association to that organization’s Council on Research. Rosol also serves on the NIH National Center for Research Resources Council and the federal USDA Advisory Board.